These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3320205)

  • 1. Removal of Langerhans cells from human epidermal cell suspensions by immunomagnetic particles.
    Nilsson H; Johansson C; Scheynius A
    J Immunol Methods; 1987 Dec; 105(2):165-9. PubMed ID: 3320205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A method for the rapid isolation of human epidermal Langerhans cells using immunomagnetic microspheres.
    Hanau D; Schmitt DA; Fabre M; Cazenave JP
    J Invest Dermatol; 1988 Sep; 91(3):274-9. PubMed ID: 3411146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T-lymphocyte-activating properties of epidermal antigen-presenting cells from normal and psoriatic skin: evidence that psoriatic epidermal antigen-presenting cells resemble cultured normal Langerhans cells.
    Demidem A; Taylor JR; Grammer SF; Streilein JW
    J Invest Dermatol; 1991 Sep; 97(3):454-60. PubMed ID: 1875046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The mixed epidermal cell-lymphocyte reaction. II. Epidermal Langerhans cells are responsible for the enhanced allogeneic lymphocyte-stimulating capacity of normal human epidermal cell suspensions.
    Sontheimer RD
    J Invest Dermatol; 1985 Jul; 85(1 Suppl):21s-26s. PubMed ID: 3159806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification of functional active epidermal Langerhans cells: a simple and efficient new technique.
    Morris J; Alaibac M; Jia MH; Chu T
    J Invest Dermatol; 1992 Aug; 99(2):237-40. PubMed ID: 1629635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enrichment of unlabeled human Langerhans cells from epidermal cell suspensions by discontinuous density gradient centrifugation.
    Teunissen MB; Wormmeester J; Kapsenberg ML; Bos JD
    J Invest Dermatol; 1988 Oct; 91(4):358-62. PubMed ID: 2844911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation of epidermal Langerhans cells.
    Schmitt DA; Hanau D; Cazenave JP
    J Immunogenet; 1989 Apr; 16(2):157-68. PubMed ID: 2687386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigen-presenting capacity in normal human dermis is mainly subserved by CD1a+ cells.
    Sepulveda-Merrill C; Mayall S; Hamblin AS; Breathnach SM
    Br J Dermatol; 1994 Jul; 131(1):15-22. PubMed ID: 7519030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effective enrichment of murine epidermal Langerhans cells by a modified(mismatched) panning technique.
    Koch F; Kämpgen E; Schuler G; Romani N
    J Invest Dermatol; 1992 Dec; 99(6):803-7. PubMed ID: 1469295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enrichment of murine and human Langerhans cells with solid phase immunoabsorption using pan-leukocyte monoclonal antibodies.
    Wood GS; Kosek J; Butcher EC; Morhenn VB
    J Invest Dermatol; 1985 Jan; 84(1):37-40. PubMed ID: 3880795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PUVA therapy decreases HLA-DR+ CDIa+ Langerhans cells and epidermal cell antigen-presenting capacity in human skin, but flow cytometrically-sorted residual HLA-DR+ CDIa+ Langerhans cells exhibit normal alloantigen-presenting function.
    Ashworth J; Kahan MC; Breathnach SM
    Br J Dermatol; 1989 Mar; 120(3):329-39. PubMed ID: 2469456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enrichment of epidermal Langerhans cells: studies with a monolayer technique and flow cytometry sorting.
    Scheynius A; Klareskog L; Forsum U; Matsson P; Karlsson L; Peterson PA; Sundström C
    J Invest Dermatol; 1982 Jun; 78(6):452-5. PubMed ID: 6211496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin 1 alpha but not transforming growth factor beta inhibits tumor antigen presentation by epidermal antigen-presenting cells.
    Grabbe S; Bruvers S; Granstein RD
    J Invest Dermatol; 1994 Jan; 102(1):67-73. PubMed ID: 8288913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo treatment with anti-I-A antibodies: differential effects on Ia antigens and antigen-presenting cell function of spleen cells and epidermal Langerhans cells.
    Aberer W; Kruisbeek AM; Shimada S; Katz SI
    J Immunol; 1986 Feb; 136(3):830-6. PubMed ID: 3455705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutrophils, differentiated macrophages, and monocyte/macrophage antigen presenting cells infiltrate murine epidermis after UV injury.
    Cooper KD; Duraiswamy N; Hammerberg C; Allen E; Kimbrough-Green C; Dillon W; Thomas D
    J Invest Dermatol; 1993 Aug; 101(2):155-63. PubMed ID: 8393901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flow cytometrically-sorted residual HLA-DR+T6+ Langerhans cells in topical steroid-treated human skin express normal amounts of HLA-DR and CD1a/T6 antigens and exhibit normal alloantigen-presenting capacity.
    Ashworth J; Kahan MC; Breathnach SM
    J Invest Dermatol; 1989 Feb; 92(2):258-62. PubMed ID: 2783952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Murine epidermal Langerhans cells mature into potent immunostimulatory dendritic cells in vitro.
    Schuler G; Steinman RM
    J Exp Med; 1985 Mar; 161(3):526-46. PubMed ID: 3871837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Langerhans cells: antigen presenting cells of the epidermis.
    Streilein JW; Bergstresser PR
    Immunobiology; 1984 Dec; 168(3-5):285-300. PubMed ID: 6397423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo ultraviolet-exposed human epidermal cells activate T suppressor cell pathways that involve CD4+CD45RA+ suppressor-inducer T cells.
    Baadsgaard O; Salvo B; Mannie A; Dass B; Fox DA; Cooper KD
    J Immunol; 1990 Nov; 145(9):2854-61. PubMed ID: 1976706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retinoic acid upregulates human Langerhans cell antigen presentation and surface expression of HLA-DR and CD11c, a beta 2 integrin critically involved in T-cell activation.
    Meunier L; Bohjanen K; Voorhees JJ; Cooper KD
    J Invest Dermatol; 1994 Dec; 103(6):775-9. PubMed ID: 7798614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.